These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1141 related items for PubMed ID: 16490581

  • 1. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
    Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C, Ho SY, House K, Dorinsky P.
    J Asthma; 2004 Jan; 41(8):797-806. PubMed ID: 15641629
    [Abstract] [Full Text] [Related]

  • 3. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
    Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
    [Abstract] [Full Text] [Related]

  • 5. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 6. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
    Lumry WR, Conway MM, LaForce CF, Pearlman DS, Scott CA, Herje NE, Wu WW, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS, Lin HC, Huang CD, Lee KY, Liu CY, Yu CT, Wang CH, Kuo HP.
    Chang Gung Med J; 2011 Jan; 34(4):382-94. PubMed ID: 21880193
    [Abstract] [Full Text] [Related]

  • 8. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
    Bateman ED, Silins V, Bogolubov M.
    Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
    [Abstract] [Full Text] [Related]

  • 9. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
    Edin HM, Andersen LB, Schoaf L, Scott-Wilson CA, Ho SY, Ortega HG.
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L, Humphries M, Du X, Wang L, Jiang J.
    Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [Abstract] [Full Text] [Related]

  • 12. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
    Boonsawat W, Goryachkina L, Jacques L, Frith L.
    Clin Drug Investig; 2008 May; 28(2):101-11. PubMed ID: 18211118
    [Abstract] [Full Text] [Related]

  • 13. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N, Williams M, Rimmer M, Kahl L, Jenkins M, SMO30006 and SMO30007 International Study Teams.
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [Abstract] [Full Text] [Related]

  • 14. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL, Noonan MJ, Weinstein SF, Chervinsky P, Scott CA, Herje NE, Wu W, Crim C.
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [Abstract] [Full Text] [Related]

  • 15. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A, Jacques L, Frith L.
    Clin Drug Investig; 2008 Dec; 28(3):169-81. PubMed ID: 18266402
    [Abstract] [Full Text] [Related]

  • 16. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ, Currie GP, Lipworth BJ.
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [Abstract] [Full Text] [Related]

  • 17. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
    Can Respir J; 1999 Jun; 6(1):45-51. PubMed ID: 10202220
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 19. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 20. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ, Allen D, McDonnell B, Wheeler N, Sharma RK, Sykes A, Woodcock A.
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.